- 105
- 293 368
Samsung Biologics
South Korea
เข้าร่วมเมื่อ 12 พ.ค. 2014
Welcome to the official Samsung Biologics TH-cam channel.
With proven regulatory approvals, the largest single site capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to provide seamless offerings from development, manufacturing, to laboratory testing services at every stage for biopharmaceutical products while meeting the evolving needs of the global healthcare industry.
By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our clients working together to achieve "Better Life" for all humanity through biomedicines.
Please subscribe to see what's happening at Samsung Biologics and for all the latest news, visit our website at samsungbiologics.com.
With proven regulatory approvals, the largest single site capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to provide seamless offerings from development, manufacturing, to laboratory testing services at every stage for biopharmaceutical products while meeting the evolving needs of the global healthcare industry.
By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our clients working together to achieve "Better Life" for all humanity through biomedicines.
Please subscribe to see what's happening at Samsung Biologics and for all the latest news, visit our website at samsungbiologics.com.
[Webinar] Application of QbD approach for tech transfer and process characterization of biologics
A strategic approach that ensures the high quality of drugs by employing statistical and risk-management methodology, Quality by Design can be applied for effective and efficient tech transfer and process characterization. Learn more from our Senior Director of the Multi Modality MSAT Team @Youngsun Kim in this recent webinar.
✅LINK: samsungbiologics.com/kr/media/science-technology/application-of-qbd-approach-for-tech-transfer-and-process-characterization-of-biologics
#samsungbiologics #qbd #techtransfer
✅LINK: samsungbiologics.com/kr/media/science-technology/application-of-qbd-approach-for-tech-transfer-and-process-characterization-of-biologics
#samsungbiologics #qbd #techtransfer
มุมมอง: 86
วีดีโอ
![[Webinar] Samsung Biologics Capacity Update (N-1 perfusion, PFS)](http://i.ytimg.com/vi/-_zV6z6ubGw/mqdefault.jpg)
![[Webinar] Samsung Biologics Capacity Update (N-1 perfusion, PFS)](/img/tr.png)
[Webinar] Samsung Biologics Capacity Update (N-1 perfusion, PFS)
มุมมอง 153หลายเดือนก่อน
Biologics development is complex, making it essential to have a CDMO partner with both the expertise and capacity to support each stage of the journey. Join John Gagliardi, Manager in CMO Sales, as he discusses our expanded service offerings and growth in the ADC space. Watch the webinar on demand: ✅LINK: samsungbiologics.com/kr/media/science-technology/samsung-biologics-capacity-update-n-1-per...
![[Webinar] Introducing Two New Highly Effective ADC Payloads for Cancer Therapeutics](http://i.ytimg.com/vi/CHxIbwypSeQ/mqdefault.jpg)
[Webinar] Introducing Two New Highly Effective ADC Payloads for Cancer Therapeutics
มุมมอง 106หลายเดือนก่อน
While antibody-drug conjugates (ADC) are emerging as a promising class of anti-cancer treatment, access to effective therapeutic agents remains limited. In this webinar, we delve into the importance of choosing high-quality payloads in ADC development and how our novel payload technologies can support increased efficacy and safety. ✅LINK: samsungbiologics.com/media/science-technology/introduci...
Accelerate Your Success with Samsung Biologics’ CMO Services
มุมมอง 286หลายเดือนก่อน
Discover Samsung Biologics' unmatched CMO technologies and services designed to accelerate your product journey from clinical to commercial manufacturing. With the world-class production capacity, flexible offerings, and a commitment to quality, we deliver excellence at every stage. Learn how our state-of-the-art facilities support seamless scaling and high throughput for your success. #samsung...
Explore Samsung Biologics’ Advanced Technologies
มุมมอง 3312 หลายเดือนก่อน
Our tailored services and proven expertise are designed to meet the unique needs of your complex molecules. Explore Samsung Biologics’ advanced biomanufacturing technologies in our state-of-the-art plants. #SamsungBiologics #Manufacturing #CDMO #ComplexMolecule
![[Webinar] Innovative approaches to enhance cell culture density for high-quality production](http://i.ytimg.com/vi/tQJoHj_iaRc/mqdefault.jpg)
[Webinar] Innovative approaches to enhance cell culture density for high-quality production
มุมมอง 2322 หลายเดือนก่อน
Recent innovations in intensified fed-batch (IFB) processing have led to substantial improvements in cell culture yields and scalability, driving more efficient biopharmaceutical production. Watch our on-demand webinar, in collaboration with BPI, where our upstream process development scientists discuss the latest advancements in IFB processing and how our S-Tensify™ platform ensures consistent...
Dedicated Antibody-Drug Conjugates (ADC) Facility
มุมมอง 7302 หลายเดือนก่อน
Our dedicated, standalone antibody-drug conjugates (ADC) facility is on track for completion within this year. Located across from both Bio Campus I and II, the facility will enable us to offer seamless services from development to manufacturing for your ADC project. Stay tuned for additional updates as we advance to provide innovative therapeutics. samsungbiologics.com/services/adc #SamsungBio...
One-stop mRNA Manufacturing, Samsung Biologics
มุมมอง 3952 หลายเดือนก่อน
At Samsung Biologics, we offer one-stop mRNA manufacturing from start to finish, all at a single site where our experts serve you through a fully-equipped MSAT laboratory, dedicated to mRNA. As a trusted navigator in your novel path to success, we are here to help you forge ahead towards the next breakthrough. To find out more about our offerings, please watch the video.
![[Webinar] Formulation Considerations for the Development of High Concentration Biopharmaceuticals](/img/n.gif)
[Webinar] Formulation Considerations for the Development of High Concentration Biopharmaceuticals
มุมมอง 2002 หลายเดือนก่อน
This webinar discusses the challenges of developing high-concentration biopharmaceutical formulations, such as increased aggregation, viscosity, and opalescence. It also presents case studies on how to manage these issues and practical strategies for streamlining the formulation process, with a focus on enabling subcutaneous administration for patient convenience. 👉 Link: samsungbiologics.com/m...
[Webinar] Trusted end-to-end CDMO partner for your journey | OPCU Webinar
มุมมอง 5365 หลายเดือนก่อน
[Webinar] Trusted end-to-end CDMO partner for your journey | OPCU Webinar
[Webinar] Manufacturing concepts for antibody-drug conjugates | Webinar
มุมมอง 2.7K6 หลายเดือนก่อน
[Webinar] Manufacturing concepts for antibody-drug conjugates | Webinar
Harnessing Analytical Development To Empower Process Development For Successful Manufacturing
มุมมอง 3686 หลายเดือนก่อน
Harnessing Analytical Development To Empower Process Development For Successful Manufacturing
[Webinar] Expediting Biologics preclinical development timeline through downstream strategies
มุมมอง 1.2K8 หลายเดือนก่อน
[Webinar] Expediting Biologics preclinical development timeline through downstream strategies
[Webinar] Navigating challenges during formulation development
มุมมอง 9588 หลายเดือนก่อน
[Webinar] Navigating challenges during formulation development
[Webinar] Reducing candidate risk with a robust developability assessment tool
มุมมอง 7309 หลายเดือนก่อน
[Webinar] Reducing candidate risk with a robust developability assessment tool
[Webinar] Enhancing quality by employing cell line replacement and process optimization
มุมมอง 1.2Kปีที่แล้ว
[Webinar] Enhancing quality by employing cell line replacement and process optimization
BIO PLAZA | Your one-stop place to achieve your well-being
มุมมอง 1.2Kปีที่แล้ว
BIO PLAZA | Your one-stop place to achieve your well-being
[Webinar] Expanding Samsung Biologics’ business into Late Discovery/Early Development
มุมมอง 672ปีที่แล้ว
[Webinar] Expanding Samsung Biologics’ business into Late Discovery/Early Development
[Webinar] Optimizing N-glycan Profiles and their effector functions
มุมมอง 723ปีที่แล้ว
[Webinar] Optimizing N-glycan Profiles and their effector functions
[Webinar] S-DUAL™: A novel bispecific antibody scaffold with enhanced heterodimer formation and ...
มุมมอง 1.1Kปีที่แล้ว
[Webinar] S-DUAL™: A novel bispecific antibody scaffold with enhanced heterodimer formation and ...
[Webinar] Driving force of Samsung Biologics’ competitiveness | Leadership Insights (KOR sub)
มุมมอง 1.3Kปีที่แล้ว
[Webinar] Driving force of Samsung Biologics’ competitiveness | Leadership Insights (KOR sub)
[Webinar] Designing an mRNA process development platform: a quality by design approach
มุมมอง 2.4Kปีที่แล้ว
[Webinar] Designing an mRNA process development platform: a quality by design approach
Life Sciences Knowledge Hub | Interview with Senior Vice President Kevin Sharp
มุมมอง 732ปีที่แล้ว
Life Sciences Knowledge Hub | Interview with Senior Vice President Kevin Sharp
[Webinar] Tackling false-positive endotoxin results in downstream process
มุมมอง 1.7Kปีที่แล้ว
[Webinar] Tackling false-positive endotoxin results in downstream process
Life Sciences Knowledge Hub | Interview with Executive Vice President James Choi
มุมมอง 1.9Kปีที่แล้ว
Life Sciences Knowledge Hub | Interview with Executive Vice President James Choi
[Webinar] Business Review | Partnering with CDMOs for a sustainable future
มุมมอง 1.9Kปีที่แล้ว
[Webinar] Business Review | Partnering with CDMOs for a sustainable future